Creative Biolabs-Immuno-oncology

Anti-CD5 (clone T1G0Z1G) SynExpress T7-G-L/T-E Modified CD8+ T cells (CAT#: ITS-1224-CR1666)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD5 (clone T1G0Z1G). We employs the Lentivirus (T7-GFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Exons Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD5
Clone
T1G0Z1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.92
Cell Culture
Microcarrier Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving